Gaudium IVF and Women Health listed at a 5% premium over its IPO price, despite a flat GMP. The IPO saw strong retail and NII demand, and proceeds will fund new IVF centres and loan repayment.The IPO, which closed on February 24, was subscribed 7.27 times overall. The retail category was subscribed 7.60 times, while the NII portion saw strong demand at 14.05 times.